This is a profile image of Jake Henry

Jake Henry

Senior PartnerChicago

Jake Henry

Senior PartnerChicago

Leads McKinsey’s global work on mergers, acquisitions, separations, divestitures and JV’s/alliances. Serves leading medical technology and biopharma/biotech companies in setting strategy, pursuing growth opportunities, and achieving operational excellence.

Jake is a global coleader of McKinsey's M&A Practice, which includes mergers, acquisitions, integrations, joint ventures, and divestitures. Previously, he was the coleader of our Life Sciences Practice globally, where for more than 20 years, he guided pharmaceutical and medical-technology company executives on matters of corporate strategy, growth strategy, and operational excellence.

Jake is also one of our longest-standing advisors to the medical-products industry and has helped many of the world’s leading providers of medical devices navigate the rapidly changing value chain. Drawing on a technical background, he appreciates the potential for each new wave of technical advance to have a profound impact on patient care. He also advises private-equity companies seeking healthcare-related mergers and acquisitions.

An expert on changes in US healthcare, Jake speaks frequently at conferences and on professional panels across North America. Most recently, he gave the keynote speech at a meeting of the American Diagnostics Association.

Jake serves on the Board of the Boys and Girls Club of Chicago and recently chaired the Youth of the Year competition. He also serves on the Board of Visitors of the Pratt School of Engineering at Duke University.

Published work

Top M&A trends in 2024: Blueprint for success in the next wave of deals,” McKinsey & Company, February 2024


Duke University
PhD, mechanical engineering
BEng, mechanical engineering, biomedical engineering